RetractedArticleBioengineered2022

LncRNA SNHG10 suppresses the development of doxorubicin resistance by downregulating miR-302b in triple-negative breast cancer.

Shataer Aini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.